Related Experiment Video
Updated: Mar 5, 2026

06:16
mirMachine: A One-Stop Shop for Plant miRNA Annotation
Published on: May 1, 2021
3.0K
PBMDA: A novel and effective path-based computational model for miRNA-disease association prediction
Zhu-Hong You1, Zhi-An Huang2, Zexuan Zhu2
1Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Science, ürümqi, China.
Plos Computational Biology
|March 25, 2017
Summary
This study introduces the Path-Based MiRNA-Disease Association (PBMDA) model to predict links between microRNAs (miRNAs) and diseases. PBMDA effectively identifies potential miRNA-disease associations, aiding in understanding disease mechanisms and drug development.
Area of Science:
- Genomics
- Bioinformatics
- Computational Biology
Background:
- MicroRNAs (miRNAs) are crucial regulators in biological processes.
- The molecular mechanisms of complex human diseases involving miRNAs are not fully understood.
- Predicting miRNA-disease associations aids disease pathogenesis research, drug development, and personalized medicine.
Purpose of the Study:
- To develop a computational model for predicting potential miRNA-disease associations.
- To prioritize candidate miRNAs for specific diseases for experimental validation.
- To enhance understanding of miRNA roles in complex human diseases.
Main Methods:
- Proposed the Path-Based MiRNA-Disease Association (PBMDA) model.
- Integrated known miRNA-disease associations, miRNA functional similarity, disease semantic similarity, and Gaussian interaction profile kernel similarity.
- Constructed a heterogeneous graph and used a depth-first search algorithm for association inference.
Main Results:
- PBMDA demonstrated reliable performance in leave-one-out cross-validation (LOOCV) with AUCs of 0.8341 and 0.9169.
- Achieved an average AUC of 0.9172 in 5-fold cross-validation.
- Case studies showed 88-90% validation of top predicted miRNAs for Esophageal, Kidney, and Colon Neoplasms from literature.
Conclusions:
- PBMDA is a powerful computational tool for accelerating the identification of disease-miRNA associations.
- The model offers a cost-effective alternative to time-consuming biological experiments.
- Findings contribute to understanding disease pathogenesis and developing targeted therapies.
Related Concept Videos
MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs
24.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K

